Cytokinetics EBITDA 2010-2024 | CYTK
- Cytokinetics 2024 EBITDA was -0.527B, a 8.76% increase from 2023.
- Cytokinetics 2023 EBITDA was -0.484B, a 52.11% increase from 2022.
- Cytokinetics 2022 EBITDA was -0.318B, a 73% increase from 2021.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.